Screener
Palvella Therapeutics PVLA Total Revenue
Discontinued — last reported Q1 '24
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Palvella Therapeutics’s 10-Q, filed May 15, 2024.
- Filed
- May 15, 2024
- Fiscal quarter
- Q1 FY2024
- Calendar quarter
- Q1 2024
- Accession
- 0001437749-24-017037
| Line item | Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 |
|---|---|---|
| Revenue | ||
| Customer revenue | $6 | $2,010 |
| Collaboration revenue | 47 | (74) |
| Total revenue | 53 | 1,936 |
| Operating expenses | ||
| Research and development | 1,218 | 13,424 |
| General and administrative | 4,138 | 4,023 |
| Total operating expenses | 5,356 | 17,447 |
Item 1. Financial Statements.
FAQ
- What is Palvella Therapeutics's total revenue?
- Palvella Therapeutics (PVLA) reported total revenue of $53K in Q1 2024.
- How has Palvella Therapeutics's total revenue changed year-over-year?
- Palvella Therapeutics's total revenue decreased by 97.3% year-over-year, from $1.94M to $53K.
- What is the long-term trend for Palvella Therapeutics's total revenue?
- Over 2 years (2021 to 2023), Palvella Therapeutics's total revenue has grown at a 16.7% compound annual growth rate (CAGR), from $31.42M to $42.81M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Palvella Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude